Outcomes Data of Adipose Stem Cells to Treat Chronic Obstructive Pulmonary Disease

Status unconfirmed

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

The purpose of this study is to determine the impact that treatment with a cellular concentrate derived from an individual's own fat, known as the stromal vascular fraction (SVF), has on the quality of life of people with chronic obstructive pulmonary disease (COPD). SVF contains multiple cellular components, including stem cells, with both regenerative and anti-inflammatory properties. This therapy has shown promise for ameliorating the symptoms of COPD. This study is designed to evaluate quality of life changes in individuals with COPD for up to 12 months following SVF treatment.

Key facts

Study ID

NCT02348060

Run by

StemGenex

People needed

100

Starts

2015-11-01

Expected to finish

2019-05-01

Last updated by the study team

2018-08-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects diagnosed with chronic obstructive pulmonary disease (COPD)
• Subjects scheduled for a stem cell/SVF treatment
• Subjects willing and able to sign informed consent
• Subjects willing and able to perform follow-up interviews and surveys

You may not qualify if…

• Subjects with additional major health condition/disease diagnoses
• Subjects that are pregnant or breastfeeding

Where it is running

• StemGenex — San Diego, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.